Versuchen GOLD - Frei
Top law firm partners defy risks to start boutique firms
Mint Chennai
|October 08, 2025
Karishma Sundara had already spent six years working at India's top law firms before joining Trilegal, another marquee name in the country's legal profession, as an equity partner three years ago.
But an "irrefutable desire" to start her own practice lingered. In August, boutique legal services provider Kintsugi Law was born.
"I've helped entities shape and deploy compliant, impactful tech products and features for years -there's no better way to be bitten by the entrepreneurial bug," said the first-generation lawyer. She named her firm after the Japanese art form of repairing broken pottery with gold-mixed lacquer, signifying transformation while preserving the old.
At least 10 partners from firms like Cyril Amarchand, Trilegal, and AZB & Partners started own ventures in the past year.
Repeats every few years. This time, the scale of opportunity is bigger, driven by a growing economy and investments. The industry is also facing elevated churn as firms poach high-profile partners ahead of foreign entry. Clients are strengthening in-house legal teams, raising the risk for new, independent firms.
Diese Geschichte stammt aus der October 08, 2025-Ausgabe von Mint Chennai.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Mint Chennai
Mint Chennai
Lenskart wants artificial intelligence to test your eyes
It expects AI-enabled eye testing to become the default foundational layer of eyecare delivery
3 mins
January 13, 2026
Mint Chennai
More companies to take a hit as labour codes debut
Reworked gratuity and leave encashments spell additional expenses for India Inc
2 mins
January 13, 2026
Mint Chennai
HC lifts ban on Zydus cancer biosimilar till patent expiry
In a relief for Zydus Lifesciences, a division bench of the Delhi High Court on Monday allowed the drugmaker to sell and market its biosimilar of the anticancer drug nivolumab in India, citing public interest.
2 mins
January 13, 2026
Mint Chennai
Trump’s investigation of Powell is also a warning to the next Fed chair
The criminal investigation into Federal Reserve Chair Jerome Powell isn’t ultimately about the Fed’s headquarters, or Powell, or even interest rates.
3 mins
January 13, 2026
Mint Chennai
States flag Almont-Kid syrup as tests find contaminants
Syrup found ‘Not of Standard Quality’ with contaminants like toxic ethylene glycol
1 mins
January 13, 2026
Mint Chennai
India at 100: Our choices today will define the next two decades
India's 2047 ambition is not guaranteed but achievable if we address all the potential pitfalls along our development path
4 mins
January 13, 2026
Mint Chennai
Now, inheritance works without probate—but why it still matters
Heirs can now act on a valid will without court cases, easing delays and unlocking assets in undisputed cases
6 mins
January 13, 2026
Mint Chennai
Why VCs have a new deep-tech playbook
where fundraising starts to drag,\" said Chand.
1 min
January 13, 2026
Mint Chennai
TCS, HCLTech deliver Q3 revenue surprise
clearer.
2 mins
January 13, 2026
Mint Chennai
US productivity is rising and it risks warping monetary policy
America's neutral rate ought to be going up but will the Fed listen?
3 mins
January 13, 2026
Listen
Translate
Change font size
